Epidemiological modelling (including economic modelling) and its role in preventive drug therapy
Author:
Affiliation:
1. Epidemiological Modelling Unit, Department of Epidemiology and Preventive Medicine, Monash University Medical School, Alfred Hospital, Melbourne, VIC.
Funder
National Health and Medical Research Council
Monash University
Publisher
AMPCo
Subject
General Medicine
Link
https://onlinelibrary.wiley.com/doi/pdf/10.5694/j.1326-5377.2002.tb04839.x
Reference2 articles.
1. Use of lipid lowering drugs for primary prevention of coronary heart disease: meta-analysis of randomised trials
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Cost-Effectiveness Analysis of Rivaroxaban in Chinese Patients With Stable Cardiovascular Disease;Frontiers in Pharmacology;2022-06-20
2. Cost-effectiveness of rivaroxaban and aspirin compared to aspirin alone in patients with stable cardiovascular disease: An Australian perspective;International Journal of Cardiology;2018-11
3. Overview of pharmacoeconomic modelling methods;British Journal of Clinical Pharmacology;2013-03-15
4. An equity - effectiveness framework linking health programs and healthy life expectancy;Australian Journal of Primary Health;2011
5. Critique of an Economic Evaluation Using the Drummond Checklist;Applied Health Economics and Health Policy;2010-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3